Ginger D Constantine Selected Research

bazedoxifene

7/2015	Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence.
1/2015	Bridging analysis of the efficacy and safety of bazedoxifene in Japanese and global populations of postmenopausal women with osteoporosis.
5/2011	Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trial.
3/2011	Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal Japanese women with osteoporosis.
6/2010	Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis.
11/2009	Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis.
11/2009	Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women.
12/2008	Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ginger D Constantine Research Topics

Disease

13	Atrophy 01/2019 - 01/2014
10	Osteoporosis 07/2015 - 12/2003
9	Dyspareunia 09/2017 - 07/2015
7	Endometrial Hyperplasia 01/2019 - 11/2009
5	Endometrial Neoplasms (Endometrial Cancer) 01/2019 - 11/2009
3	Hyperplasia 01/2019 - 01/2015
3	Hemorrhage 07/2015 - 12/2009
2	Neoplasms (Cancer) 01/2019 - 11/2009
2	Breast Neoplasms (Breast Cancer) 07/2015 - 12/2003
2	Premenstrual Dysphoric Disorder 05/2012 - 01/2012
2	Uterine Hemorrhage (Uterine Bleeding) 05/2011 - 12/2006
2	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 06/2010 - 11/2009
2	Muscle Cramp (Cramp) 06/2010 - 12/2008
2	Postmenopausal Osteoporosis 06/2010 - 11/2009
1	Obesity 01/2019
1	Pruritus (Itching) 05/2017
1	Hot Flashes 01/2017
1	Metrorrhagia (Spotting) 07/2015
1	Bone Fractures (Bone Fracture) 01/2015
1	Migraine Disorders (Migraine) 01/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2014
1	Premenstrual Syndrome (Premenstrual Tension) 05/2012
1	Mastodynia 05/2011
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2010
1	Polyps 11/2009
1	Ovarian Cysts (Ovarian Cyst) 11/2009
1	Dementia (Dementias) 12/2003

Drug/Important Bio-Agent (IBA)

8	TX-004HRIBA 09/2017 - 12/2016
8	bazedoxifeneIBA 07/2015 - 12/2008
7	Capsules (Microcapsules)IBA 01/2019 - 01/2017
6	Estrogens (Estrogen)FDA Link 01/2019 - 12/2003
6	Estradiol (Delestrogen)FDA LinkGeneric 12/2018 - 01/2017
5	Raloxifene Hydrochloride (Evista)FDA Link 07/2015 - 12/2008
4	Selective Estrogen Receptor Modulators (SERM)IBA 01/2016 - 11/2009
4	Levonorgestrel (Plan B)FDA LinkGeneric 05/2012 - 12/2009
4	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 05/2012 - 12/2009
3	Hormones (Hormone)IBA 01/2019 - 12/2003
3	OspemifeneIBA 01/2016 - 01/2015
3	Oral ContraceptivesIBA 05/2012 - 12/2006
2	Tamoxifen FDA LinkGeneric 01/2019 - 07/2015
2	Progesterone FDA LinkGeneric 01/2019 - 01/2018
2	Progestins (Progestagens)IBA 01/2019 - 01/2019
1	TX-001HRIBA 01/2019
1	Conjugated (USP) Estrogens (Premarin)FDA Link 01/2019
1	Contraceptive Agents (Contraceptives)IBA 01/2019
1	antineoplaston A10 (A 10)IBA 01/2019
1	RAD1901IBA 01/2017
1	Estrogen ReceptorsIBA 01/2016

Therapy/Procedure

3	Therapeutics 01/2019 - 12/2003